In the Boardroom
Refine Search
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
Less than two year after engaging a new head of the company, Stockholm, Sweden-based biotech Medivir has appointed a new chief executive, namely Yilmaz Mahshid. 26 May 2020
Biotechnology
Privately-held Galecto has added some boardroom experience in the shape of Amit Munshi, the chief executive of Arena Pharmaceuticals, and David Shapiro, the former chief medical officer of Intercept Pharmaceuticals. 20 May 2020
Biotechnology
Oxford BioDynamics, a UK biotech focused on the discovery and development of biomarkers, based on regulatory 3D genome architecture, using its liquid biopsy platform EpiSwitch, announces that Dr Jon Burrows has been appointed as group chief executive, effective 23 March 2020. 16 March 2020
Biotechnology
German newspaper Welt am Sonntag over the weekend said that US President Donald Trump “had offered funds” to entice German mRNA-based drug specialist CureVac to move its recently started COVID-19 R&D work to the USA, and the German government was now “making counter-offers to tempt it to stay.” 16 March 2020
Biotechnology
Akcea Therapeutics, a majority-owned affiliate of Ionis Pharmaceuticals, today announced that Lisa Johnson-Pratt has joined the company as senior vice president of new product strategy. 11 March 2020
Biotechnology
Horama, the ophthalmic gene therapy company, has named Rodolphe Clerval as its chief business officer. 11 March 2020
Biotechnology
Swedish biotech Cantargia has appointed Dr Ignacio Garcia-Ribas as chief medical officer (CMO) of Cantargia effective March 1, 2020 26 February 2020
Biotechnology
Successful Danish biotech company Genmab (Nasdaq: GMAB) said late Friday that its chairman, Mats Pettersson, has decided to step down from the post on March 26, when his election period expires. 24 February 2020
Biotechnology
US biotech major Gilead Sciences announced today that Michael Quigley has joined the company as senior vice president, Research Biology, bringing to the role deep experience in oncology and immuno-oncology biology. 19 February 2020
Biotechnology
The UK’s Healx, an AI-powered and patient-inspired technology company, today announced the appointment of Dr Anthony Hall as chief medical officer (CMO). 4 February 2020
Biotechnology
US clinical-stage biotech firm Boston Pharmaceuticals has appointed Dr Craig Basson as its chief medical officer. 3 February 2020
Biotechnology
Late Thursday, French metabolic diseases biotech company Poxel announced the appointment of pharma industry veteran David Moller as chief scientific officer (CSO). 24 January 2020
Biotechnology
The Roivant Sciences company Dermavant has announced the appointment of Chris Chapman as its chief commercial officer. 22 January 2020
Biotechnology
Independent Dutch drugmaker Norgine has named Michael Lange as general manager for Germany. 20 January 2020
Biotechnology
Chinese biotech start-up Antengene recently hired two former high-profile managers from its funding partner Celgene, now a Bristol-Myers Squibb (NYSE: BMY) company. In a recent meeting in Shanghai, where Antengene is based, founder and chief executive Jay Mei spoke with The Pharma Letter about the hires and his vision for his company. 16 January 2020
Biotechnology
Having just announced the first launch of its new gene therapy Zynteglo (autologous CD34+ cells encoding βA-T87Q-globin gene), in Germany, US gene therapy company bluebird bio has appointed former Celgene executive Nicola Heffron to head up its European operations, based in Zug, Switzerland. 16 January 2020
Biotechnology
Sweden-based CNS specialist AlzeCure Pharma has appointed Martin Jönsson as its new chief executive with effect on January 9. 8 January 2020
Biotechnology
US biotech firm FibroGen has appointed Enrique Conterno as the company’s chief executive and a member of the board of directors, effective immediately. 7 January 2020
Biotechnology
US cell and gene therapy company Abeona Therapeutics saw its shares gain 4.2% to $3.75 in after-hours trading Tuesday, after it announced that the European Medicines Agency has granted the designation of Priority Medicines ( PRIME) for its ABO-102, which studies its punctual gene therapy based on adeno-associated virus 9 (AAV9) for the treatment of Sanfilippo syndrome type A (MPS IIIA). 27 December 2019
Biotechnology
Oslo-based biotech Zelluna Immunotherapy has appointed Namir Hassan as chief executive officer, replacing Miguel Forte. 19 December 2019
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze